Vanguard Global Advisers’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
Vanguard Global Advisers's PLSE Position: Q3 2026 in Review
Vanguard Global Advisers increased its Pulse Biosciences (PLSE) stake by 0.69% in Q3 2026, buying an estimated $3.84K and bringing the position to 13,289 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #1957.
Vanguard Global Advisers first reported a position in PLSE in Q1 2026 and has held it in 3 quarters since. 142 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.
- Vanguard Global Advisers held 13,289 shares of Pulse Biosciences worth $663K as of Q3 2026.
- Vanguard Global Advisers bought 91 Pulse Biosciences shares in Q3 2026, an estimated $3.84K.
- Pulse Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1957 holding.
- Vanguard Global Advisers first reported a position in Pulse Biosciences in Q1 2026 and has held it in 3 quarters since.
- 142 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.